PHIBRO ANIMAL HEALTH CORP·4

Apr 30, 7:20 PM ET

BENDHEIM JACK 4

Research Summary

AI-generated summary

Updated

Phibro (PAHC) Director & 10% Owner Jack Bendheim Sells Shares

What Happened
Jack Bendheim, a director, officer and reported 10% owner of Phibro Animal Health Corp (PAHC), sold a total of 21,120 shares in open‑market transactions between April 28 and April 30, 2026, for aggregate proceeds of approximately $1,137,594. Individual reported trades:

  • 4/28/2026: 1,652 sh @ $55.10 = $91,019
  • 4/28/2026: 4,591 sh @ $56.06 = $257,375
  • 4/28/2026: 797 sh @ $56.69 = $45,182
  • 4/29/2026: 4,002 sh @ $52.70 = $210,907
  • 4/29/2026: 3,038 sh @ $53.21 = $161,645
  • 4/30/2026: 5,805 sh @ $52.65 = $305,618
  • 4/30/2026: 1,235 sh @ $53.32 = $65,848
    These were sales (S) — not purchases — which are often routine but provide less direct evidence of bullish conviction than buys.

Key Details

  • Dates: April 28–30, 2026. Report filed April 30, 2026 (appears timely).
  • Total sold: 21,120 shares for ~ $1.14 million.
  • Price detail: reported as weighted averages per trade; underlying transaction prices ranged roughly from $52.00 to $56.875 (per filing footnotes).
  • Ownership after transaction: not specified in the summary data provided.
  • Notable footnotes:
    • Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted by BFI Co., LLC on Dec 11, 2025 (F1).
    • Some reported securities are directly held by BFI; Mr. Bendheim exercises voting/dispositive power over BFI and may be deemed to share power over those securities (F3). Other reported securities are directly held by Jack Bendheim (F10).
    • Several prices are reported as weighted averages and were executed in multiple transactions; the filer offers to provide full per‑price breakdown on request (F2, F4–F9).

Context
Because many of the sales were effected under a pre‑arranged Rule 10b5‑1 plan and some shares were held/managed through BFI Co., LLC, these transactions can reflect pre-planned, routine dispositions by a principal rather than an immediate judgment about the company’s prospects. For retail investors, purchases are generally more informative than routine sales; these filings are factual records of disposition rather than explanations of intent.